<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00066911</url>
  </required_header>
  <id_info>
    <org_study_id>030260</org_study_id>
    <secondary_id>03-N-0260</secondary_id>
    <nct_id>NCT00066911</nct_id>
  </id_info>
  <brief_title>Brain Mapping of Voice Control</brief_title>
  <official_title>Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Some voice disorders are caused by uncontrolled muscle actions that affect the larynx or&#xD;
      voice box.&#xD;
&#xD;
      The purpose of this study is to understand 1) how the brain controls voice production; 2) how&#xD;
      changes in sensation within the voice box affect brain control of the voice box; 3) how the&#xD;
      central nervous system is affected when people have motor or sensory abnormalities that&#xD;
      affect the voice box; and 4) whether patients with voice disorders differ from people without&#xD;
      voice disorders in the way the brain controls the voice box. By better understanding these&#xD;
      concepts, researchers hope to develop improved treatments for patients with voice disorders.&#xD;
&#xD;
      Forty-five healthy adult volunteers and 90 patients with voice disorders will participate in&#xD;
      this study. Participants must be between the ages of 20 and 70. The study will involve two&#xD;
      visits to the Clinical Center. During the first visit, participants will undergo a medical&#xD;
      history and physical exam. During the second visit, investigators will perform the following&#xD;
      procedures on study participants: 1) look at the voice box with a nasolaryngoscope, a fine&#xD;
      tube through the nose; 2) use MRI [magnetic resonance imaging] to record brain activity while&#xD;
      participants use their voice to speak; 3) changing sensation in the voice box by dripping a&#xD;
      topical anesthetic onto the vocal folds; and 4) using MRI to again record brain activity&#xD;
      during speech immediately after applying the topical anesthetic.&#xD;
&#xD;
      Participants will receive up to $700 in compensation for their involvement in this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The neural organization of laryngeal motor and somatosensory function will be investigated in&#xD;
      adults with idiopathic voice disorders using functional magnetic resonance imaging. Brain&#xD;
      activation will be compared in normal volunteers and patients with spasmodic dysphonia (SD),&#xD;
      muscle tension dysphonia (MTD) and vocal tremor. While each voice disorder is characterized&#xD;
      by strained vocalization, the disorders are distinguished by other differences in voice&#xD;
      symptoms. Accordingly, the brain correlates of vocalization in these disorders may both&#xD;
      differ from each other and that of normal vocal function. Because sensory feedback has been&#xD;
      identified as a factor in SD, the role of afferent input in vocalization will be investigated&#xD;
      by comparing brain activation before and after topical anesthesia of the laryngeal mucosa.&#xD;
      The afferent blockade is expected to significantly suppress dysphonic symptoms in SD patients&#xD;
      for the duration of the block. The change in symptomatology may be associated with a&#xD;
      temporary but significant change in central sensorimotor patterns in these patients. The&#xD;
      block is not expected to alter MTD, vocal tremor or normal vocal function. The brain&#xD;
      activation changes that accompany symptom relief in SD patients will determine alterations in&#xD;
      central neural control that have a role in symptom generation in SD. Identifying these&#xD;
      differences in central sensorimotor control between the disorders will provide insight into&#xD;
      their differences in pathophysiology.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        1. To determine if emotional vocalization and linguistic vocalization involve different&#xD;
           cortical and sub-cortical functional networks in normal adults.&#xD;
&#xD;
        2. To determine if only the brain activation network active for linguistic vocalization&#xD;
           network differs between normal controls and dysphonia patients during equivalent voice&#xD;
           production effort.&#xD;
&#xD;
        3. To determine if patients with dysphonia differ from controls during the performance of&#xD;
           non-vocal laryngeal gestures when patients are asymptomatic.&#xD;
&#xD;
        4. To determine if a reduction in sensation during topical anesthesia alters linguistic&#xD;
           vocalization in dysphonia but not in controls.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2, 2003</start_date>
  <primary_completion_date type="Actual">November 5, 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>174</enrollment>
  <condition>Voice Disorders</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        The inclusion criteria for normal volunteers are normal vocal function and average health&#xD;
        as determined by the staff otolaryngologist. Normal vocal function refers to normal voice&#xD;
        quality, a negative history for voice or laryngeal disorders. Persons with significant&#xD;
        pulmonary, neurological and psychiatric function will not be recruited. The primary&#xD;
        inclusion criteria for the voice disordered groups are a current diagnosis of spasmodic&#xD;
        dysphonia (abductor or adductor type), muscular tension dysphonia or voice tremor. These&#xD;
        persons will not have pulmonary, neurological or psychiatric disorders or exclusion&#xD;
        criteria.&#xD;
&#xD;
        INCLUSION CRITERIA - for Patients with Spasmodic Dysphonia:&#xD;
&#xD;
        Intermittent strained hoarseness, uncontrolled voice breaks or changes in pitch are present&#xD;
        during vowels, liquids (r &amp; l) and semi-vowels (w &amp; y), during speech for adductor SD or&#xD;
        prolonged voiceless consonants producing breathy breaks for abductor SD;&#xD;
&#xD;
        Less prominent symptoms during whisper, singing or falsetto,&#xD;
&#xD;
        Normal voice and vocal fold movement for protective and emotional laryngeal function, such&#xD;
        as cough, laugh or cry;&#xD;
&#xD;
        A diagnosis of adductor or adductor spasmodic dysphonia based on voice testing and&#xD;
        fiberoptic nasolaryngoscopy by a board certified otolaryngologist and Speech-Language&#xD;
        Pathologist during the initial interview;&#xD;
&#xD;
        Exclusion of other laryngeal pathologies based on a fiberoptic nasolaryngoscopic&#xD;
        examination conducted during the initial interview by the staff otolaryngologist.&#xD;
&#xD;
        INCLUSION CRITERIA - for Patients with Muscular Tension Dysphonia:&#xD;
&#xD;
        Increased phonatory muscle tension in the paralaryngeal and suprahyoid muscles on&#xD;
        palpation;&#xD;
&#xD;
        A consistent hypertonic laryngeal posture for phonation, such as either an&#xD;
        anterior-posterior squeeze (pin-hole posture) or ventricular hyper adduction and an absence&#xD;
        of SD or vocal tremor as determined by a Speech-Language Pathologist and the staff&#xD;
        otolaryngologist;&#xD;
&#xD;
        Exclusion of other laryngeal pathologies based on a fiberoptic nasolaryngoscopic&#xD;
        examination conducted during the initial interview by the staff otolaryngologist.&#xD;
&#xD;
        INCLUSION CRITERIA - for Patients with Vocal Tremor:&#xD;
&#xD;
        Vocal tremor during vocalization that primarily involves laryngeal structures;&#xD;
&#xD;
        Exclusion of other laryngeal pathologies based on a fiberoptic nasolaryngoscopic&#xD;
        examination conducted during the initial interview by the staff otolaryngologist.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        Any individual with a history of one or more of the following contraindications will be&#xD;
        excluded from the study:&#xD;
&#xD;
        Airway obstruction, smoking or tobacco use;&#xD;
&#xD;
        Pulmonary, or neurological disease;&#xD;
&#xD;
        Pregnancy as reported by the volunteer or a positive pregnancy result from a urine sample&#xD;
        obtained on the day of testing;&#xD;
&#xD;
        Psychiatric disorder, under psychiatric care, or on medication for psychiatric disorders.&#xD;
        Examples of psychiatric disorders to be excluded are: somatoform disorders, conversion&#xD;
        disorders, major depression, schizophrenia or a bipolar disorder. A history of a previous&#xD;
        episode of minor reactive depression would not exclude a person from participation;&#xD;
&#xD;
        Speech or hearing problems as determined by medical history and examination by the&#xD;
        otolaryngologist. A 30 dB HL hearing screening between 500 and 3000 Hz will be conducted if&#xD;
        subjects report difficulty following spoken instructions or significant noise exposure;&#xD;
&#xD;
        A reduction in the range of vocal fold movement during non-speech tasks such as whistling&#xD;
        suggesting either paralysis or paresis, joint abnormality or neoplasm as determined by&#xD;
        videolaryngoscopic examination by the staff otolaryngologist;&#xD;
&#xD;
        Complete aphonia, a history of airway obstruction or structural abnormalities affect the&#xD;
        larynx such as vocal fold nodules, polyps, carcinoma, cysts, contact ulcers, chronic&#xD;
        laryngitis as determined by videolaryngoscopic examination by the staff otolaryngologist;&#xD;
&#xD;
        Individuals having any condition that would present unnecessary risk to them, e.g.,&#xD;
        claustrophobia.&#xD;
&#xD;
        Specific contraindications for magnetic resonance imaging include: i) Any implant or&#xD;
        surgical clip - implanted neural stimulator, implanted cardiac pacemaker or&#xD;
        autodefibrillator, cochlear implant, ocular implant, aneurysm clip, artificial heart valve,&#xD;
        insulin pump, orthopedic pins or prosthesis; ii) Any ferromagnetic foreign body - metal&#xD;
        shavings, shrapnel, orthodontic braces, certain tattoos or permanent eye liner; and, iii)&#xD;
        Any other implanted device or foreign body not listed above that is possibly ferromagnetic.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ludlow CL, Schulz GM, Yamashita T, Deleyiannis FW. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1995 Dec;104(12):928-35.</citation>
    <PMID>7492063</PMID>
  </reference>
  <reference>
    <citation>Dworkin JP, Meleca RJ, Simpson ML, Garfield I. Use of topical lidocaine in the treatment of muscle tension dysphonia. J Voice. 2000 Dec;14(4):567-74.</citation>
    <PMID>11130113</PMID>
  </reference>
  <reference>
    <citation>JÃ¼rgens U. Neural pathways underlying vocal control. Neurosci Biobehav Rev. 2002 Mar;26(2):235-58. Review.</citation>
    <PMID>11856561</PMID>
  </reference>
  <verification_date>November 5, 2009</verification_date>
  <study_first_submitted>August 6, 2003</study_first_submitted>
  <study_first_submitted_qc>August 6, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2003</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <keyword>Functional Magnetic Resonance Imaging</keyword>
  <keyword>Vocalization</keyword>
  <keyword>Spasmodic Dysphonia</keyword>
  <keyword>Muscular Tension Dysphonia</keyword>
  <keyword>Topical Lidocaine</keyword>
  <keyword>Voice Disorders</keyword>
  <keyword>Vocal Tremor</keyword>
  <keyword>Healthy Volunteer</keyword>
  <keyword>HV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Voice Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

